Abstract:CDK9 is a member of the CDC2-like family of kinases. Its cyclin partners are members of the CYCLIN T family (T1, T2a, and T2b) and CYCLIN K. The CDK9/CYCLIN T1 complex is very important in the differentiation programme of several cell types, controlling specific differentiation pathways. Limited data are available regarding the expression of CDK9/CYCLIN T1 in haematopoietic and lymphoid tissues. The aim of this study was to analyse the expression of the CDK9/CYCLIN T1 complex in lymphoid tissue, in order to assess its role in B- and T-cell differentiation and lymphomagenesis. CDK9/CYCLIN T1 expression was found by immunohistochemistry in precursor B and T cells. In peripheral lymphoid tissues, germinal centre cells and scattered B- and T-cell blasts in interfollicular areas expressed CDK9/CYCLIN T1, while mantle cells, plasma cells, and small resting T-lymphocytes displayed no expression of either molecule. CDK9/CYCLIN T1 expression therefore appears to be related to particular stages of lymphoid differentiation/activation. CDK9 and CYCLIN T1 were highly expressed in lymphomas derived from precursor B and T cells, from germinal centre cells, such as follicular lymphomas, and from activated T cells (ie anaplastic large cell lymphomas). Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma also showed strong nuclear staining. Diffuse large B-cell, Burkitt's lymphomas, and peripheral T-cell lymphomas, among T-cell lymphoproliferative disorders, showed a wide range of values. No expression of CDK9 or CYCLIN T1 was detected in mantle cell and marginal zone lymphomas. However, at the mRNA level, an imbalance in the CDK9/CYCLIN T1 ratio was found in follicular lymphoma and diffuse large B-cell lymphomas with germinal centre phenotype, and in the cell lines of classical Hodgkin's lymphomas, Burkitt's lymphomas, and anaplastic large cell lymphoma, in comparison with reactive lymph nodes. These results suggest that the CDK9/CYCLIN T1 complex may affect the activation and differentiation programme of lymphoid cells. The molecular mechanism through which the CDK9/CYCLIN T1 complex is altered in malignant transformation needs to be elucidated.

Coronin-1 Expression in T Lymphocytes: Insights into Protein Function During T Cell Development and Activation.

Coronin-1A Links Cytoskeleton Dynamics to TCRαβ-Induced Cell Signaling

Coronin 1-dependent cell density sensing and regulation of the peripheral T cell population size

The Actin Regulator Coronin 1A is Mutant in a Thymic Egress–deficient Mouse Strain and in a Patient with Severe Combined Immunodeficiency

The Coronin Family and Human Disease

Phosphorylation of Coronin 1B by Protein Kinase C Regulates Interaction with Arp2/3 and Cell Motility*

Coronin 1B Coordinates Arp2/3 Complex and Cofilin Activities at the Leading Edge.

Coronin 1B Antagonizes Cortactin and Remodels Arp2/3-containing Actin Branches in Lamellipodia.

F-actin Binding is Essential for Coronin 1B Function in Vivo

Coronin 2B Regulates Dendrite Outgrowth by Modulating Actin Dynamics.

A Novel Cytoplasmic Tail Motif Regulates Mouse Corin Expression on the Cell Surface.

Human Corin Isoforms with Different Cytoplasmic Tails That Alter Cell Surface Targeting

Coronin 6 Regulates Acetylcholine Receptor Clustering Through Modulating Receptor Anchorage to Actin Cytoskeleton

The intrinsically disordered region of coronins fine-tunes oligomerization and actin polymerization

CORO1C is Associated With Poor Prognosis and Promotes Metastasis Through PI3K/AKT Pathway in Colorectal Cancer

Ephrinb1 Is Essential In T-Cell-T-Cell Co-Operation During T-Cell Activation

Corin in Clinical Laboratory Diagnostics

Genomic Structures of the Human and Murine Corin Genes and Functional GATA Elements in Their Promoters

CD99 facilitates rearrangement of actin cytoskeleton during T cell activation.

CCDC134 Facilitates T Cell Activation Through the Regulation of Early T Cell Receptor Signaling.

CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation